Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ginsenoside Rb1 attenuates activated microglia-induced neuronal damage.
The BDNF val(66)met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.
NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS.
Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis.
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Motor cortex rTMS improves dexterity in relapsing-remitting and secondary progressive multiple sclerosis.
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Loss of Mobility and the Patient Burden of Multiple Sclerosis: Expert Opinion on Relevance to Daily Clinical Practice.
Sex drive and sexual desire.
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions.
Diagnostic accuracy of current sonographic criteria for the detection of outflow abnormalities in the internal jugular veins.
Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis.
An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.
Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis.
Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy.
Effectiveness of psychologically focused group interventions for Multiple Sclerosis: A review of the experimental literature.
Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review.
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
Elevated CSF histamine levels in multiple sclerosis patients.
Gene flow from North Africa contributes to differential human genetic diversity in southern Europe.
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.
Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia.
Pages
« first
‹ previous
…
593
594
595
596
597
598
599
600
601
…
next ›
last »